Investigation Overview
June 2, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) was announced over potential breaches of fiduciary duties by certain officers and directors at Meridian Bioscience. The investigation by a law firm concerns whether certain Meridian Bioscience officers and directors breached their fiduciary duties and ...
You must register (for free) or login to view the entire investigation.